Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic insights into the impact of prenatal viral infections on maternal and offspring immunity. | Npj Viruses | 2026 | 41606239 | PubTator, text mining | PubMed |
| B-Cells and Plasmablasts as Architects of Autoimmune Disease: From Molecular Footprints to Precision Therapeutics. | Cells | 2026 | 41597194 | PubTator, text mining | PubMed |
| A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections. | PLoS Pathog | 2026 | 41592114 | PubTator, text mining | PubMed |
| Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn. | NEJM Evid | 2026 | 41591368 | PubTator, text mining | PubMed |
| Evaluation of ASC as a therapeutic target for Alzheimer's disease. | Alzheimers Dement | 2026 | 41582303 | PubTator, text mining | PubMed |
| Recent advances in bispecific antibody-drug conjugates for breast cancer therapy. | Cancer Chemother Pharmacol | 2026 | 41579215 | PubTator, text mining | PubMed |
| Immune thrombocytopenia in patients with connective tissue disease. | Clin Rheumatol | 2026 | 41569352 | PubTator, text mining | PubMed |
| [Neurology : what's new in 2025]. | Rev Med Suisse | 2026 | 41567052 | PubTator, text mining | PubMed |
| Quantitative Prediction of Human Pharmacokinetics for Fc-Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection. | Clin Transl Sci | 2026 | 41567011 | PubTator, text mining | PubMed |
| Bispecific and multispecific T-cell engagers: advancing the future of immunotherapy. | Antib Ther | 2026 | 41561192 | PubTator, text mining | PubMed |
| Antibodies to watch in 2026. | MAbs | 2026 | 41560619 | PubTator, text mining | PubMed |
| Eculizumab as a Fast-Acting Therapy in a Myasthenic Crisis Patient With Poor Response to Efgartigimod: A Case Report. | Neurologist | 2026 | 41553721 | PubTator, text mining | PubMed |
| Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directions. | Biologics | 2026 | 41551208 | PubTator, text mining | PubMed |
| Model-based assessment of VRC07-523LS dosing in infants through population pharmacokinetic -pharmacodynamic modelling in adults and infants. | J Antimicrob Chemother | 2026 | 41549660 | PubTator, text mining | PubMed |
| Albumin Levels Are Predictive of Cachexia-Induced Time-Dependent Clearance of Therapeutic Antibodies: A Physiologically Based Pharmacokinetic Model of Durvalumab. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41543435 | PubTator, text mining | PubMed |
| Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science. | Clin Transl Sci | 2026 | 41540835 | PubTator, text mining | PubMed |
| Prediction of Monoclonal Antibodies Pharmacokinetics in Human: Identification of a Reference Neonatal Fc Receptor (FcRn) Binding Affinity Using Physiologically Based Pharmacokinetic (PBPK) Modeling. | ACS Pharmacol Transl Sci | 2026 | 41536283 | PubTator, text mining | PubMed |
| Graves' disease: a new era of pathophysiology-guided therapeutics. | J Clin Endocrinol Metab | 2026 | 41530911 | PubTator, text mining | PubMed |
| A modular "Catch-and-Play" platform for rapid T-cell engager target assembly for personalised cancer treatment. | Signal Transduct Target Ther | 2026 | 41526331 | PubTator, text mining | PubMed |
| Immunotherapies in chronic immune-mediated neuropathies. | Handb Clin Neurol | 2026 | 41526145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=11